Close

Drug Injury Lawyers Blog

Updated:

Androgel, Axiron Users to File Suit against Manufacturer over Heart Attack Risk

Testosterone replacement therapy has grown into a billion dollar industry and is only expected to continue to thrive in the coming years. As the prescriptions have come pouring in, so have the reports of severe side effects caused by the relatively new medication. While it has long been known that…

Updated:

Drug Company Founder gets $3.4 Million Fine and Jail Time for Misbranding Cancer Medication

How would you feel if the chemotherapy medication you were relying on to treat your loved one’s cancer was not the drug you thought it was? What if that drug was misbranded and illegally shipped overseas from a different country? One pharmaceutical company and its founder are paying a hefty…

Updated:

Endo Health Solutions to Resolve Majority of Vaginal Mesh Lawsuits for $830M

Endo Health Solutions says it will pay approximately $830 million (pretax) to resolve about 20,000 vaginal mesh complaints against it. The manufacturer acquired American Medical Systems Holding Inc., which makes the mesh implants, in 2011. As of late February both companies were contending with about 22,000 defective medical device cases…

Updated:

New Study Shows Testosterone Drugs Have No Link to Certain Types of Cancer; Stroke Risks Remain

A new study presented at the 2014 Genitourinary Cancers Symposium showed that testosterone therapies do not have any links to prostate cancer; an original concern for medical professionals. According to an article sourced from the National Trial Lawyers, the study used information from several cancer registries to study the risk…

Updated:

Lundbeck Pharmaceuticals Hit With Stevens Johnson Syndrome Lawsuit

A Texas family has filed suit against the European drug company Lundbeck Pharmaceuticals for the injuries their son sustained after taking Onfi, an anti-seizure medication. The parents of the 11-year-old allege that the drug caused their son to develop Stevens Johnson Syndrome, a rare and extreme disorder of the skin…

Updated:

Pfizer to settle $190M Class Action Settlement over Neurontin

Pharmaceutical giant Pfizer has tentatively agreed to a $190 million class action settlement that would essentially resolve claims made by thousands of direct purchasers that the company delayed the production and implementation of generic versions of its drug Neurontin and heavily marketed it for uses unapproved by the FDA. There…

Updated:

Lawsuit Claims Bayer Failed to Warn Patients of Yaz/Yasmin Blot Clot Risk

A California woman claims to have suffered a painful blood clot after taking Yaz/Yazmin oral contraceptive. She is suing the drug manufacturer, Bayer Healthcare Pharmaceuticals, Inc. for allegedly ignoring the warning signals raised by numerous injuries and deaths related to the drug early on in its distribution. The lawsuit states…

Contact Us
Start Chat